Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Some topical treatments like corticosteroids and vitamin D analogues are effective for scalp psoriasis, but more long-term data is needed.

Finasteride helps treat frontal fibrosing alopecia, improving or stabilizing the condition in many patients.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

The conclusion is that effectively treating hair disorders is difficult due to the complex factors affecting hair growth and more research is needed to improve treatments.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Some drugs can cause serious side effects, like hypoglycemia from mix-ups, skin reactions, or depression, and while penicillamine may help rheumatoid arthritis more than auranofin, it has more severe side effects.

Instagram ads for skin, hair, and nail supplements often make broad health claims without clear ingredient information, and are not FDA-regulated.

Post-finasteride syndrome can cause lasting sexual, physical, and mental health issues with limited treatment options.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Contraceptive agents help with menstrual issues, acne, and other health conditions in teens.

Ferret hair growth starts between 0 and 4 days after melatonin treatment, with cell growth peaking in the hair germ and declining as the hair matures.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

JAK inhibitors show promise for treating hair loss in alopecia areata but need more clinical trials to confirm safety and effectiveness.

Dupilumab treatment reduces Th2-related markers and helps hair growth in alopecia areata, showing Th2's role in the condition.

Adalimumab was safe but mostly ineffective for severe alopecia areata.

Topical L-thyroxine may help with wound healing and hair growth but should be used short-term due to potential risks.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.

Finasteride and minoxidil are approved treatments for hair loss, and hair transplants can be effective but require careful patient selection.

Medicines called 5-alpha-reductase inhibitors, like finasteride and dutasteride, are useful for treating enlarged prostate and male pattern hair loss.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Targeting the endocannabinoid system might help reduce hair pulling in trichotillomania.

Apremilast shows promise for several skin conditions but needs more research.